Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D2LUK7
|
|||
| Drug Name |
PF-06936308
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25] | Phase 1 | [1] | |
| Triple negative breast cancer [ICD-11: 2C60-2C65] | Phase 1 | [1] | ||
| Company |
Pfizer
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03674827) Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.